Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹241 Cr₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr

What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES is ₹241 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹241 Cr
Mar2024₹280 Cr
Mar2023₹23 Cr
Mar2022₹-44 Cr
Mar2021₹-30 Cr

How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹241 Cr
-13.91
Mar2024 ₹280 Cr
1,129.76
Mar2023 ₹23 Cr
Positive
Mar2022 ₹-44 Cr
Negative
Mar2021 ₹-30 Cr -

Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,855.2 Cr -2.3% -6.7% -9.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr -0.6% 9.4% 44.1% Stock Analytics
CIPLA ₹109,200.0 Cr 1.9% 2% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -0.4% 9.5% 10.5% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-2.3%

-6.7%

-9.9%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses